SuperworthCorMedix shares outstanding CRMD
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 92.5M
- On a year earlier
- +28.6%
- more shares
CorMedix had 92.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 28.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 94.1M | +53% |
| FY2024 | 61.5M | +7% |
| FY2023 | 57.4M | +37% |
| FY2022 | 41.9M | +10% |
| FY2021 | 38.1M | +18% |
| FY2020 | 32.4M | +26% |
| FY2019 | 25.7M | +92% |
| FY2017 | 13.3M | +65% |
| FY2016 | 8.1M | +15% |
| FY2015 | 7M | +58% |
| FY2014 | 4.5M | +38% |
| FY2013 | 3.2M | +42% |
| FY2012 | 2.3M | +0% |
| FY2011 | 2.3M | −7% |
| FY2010 | 2.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 92.5M | +29% | |
| Q1 FY26 | 93M | +35% | |
| Q4 FY25 | 94.1M | +53% | |
| Q3 FY25 | 86.2M | +47% | |
| Q2 FY25 | 71.9M | +25% | |
| Q1 FY25 | 69M | +20% | |
| Q4 FY24 | 61.5M | +7% | |
| Q3 FY24 | 58.8M | +4% | |
| Q2 FY24 | 57.6M | +27% | |
| Q1 FY24 | 57.5M | +30% | |
| Q4 FY23 | 57.4M | +37% | |
| Q3 FY23 | 56.6M | +37% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on CorMedix
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.